{{Rsnum
|rsid=606458
|Gene=SF1
|Chromosome=11
|position=64778919
|Orientation=minus
|GMAF=0.3361
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SF1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 79.6 | 19.5 | 0.9
| HCB | 37.8 | 43.7 | 18.5
| JPT | 39.6 | 43.2 | 17.1
| YRI | 4.8 | 33.3 | 61.9
| ASW | 15.8 | 45.6 | 38.6
| CHB | 37.8 | 43.7 | 18.5
| CHD | 37.0 | 46.3 | 16.7
| GIH | 60.0 | 38.0 | 2.0
| LWK | 7.3 | 40.0 | 52.7
| MEX | 53.4 | 39.7 | 6.9
| MKK | 10.9 | 37.8 | 51.3
| TSI | 78.4 | 20.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21768215
|Trait=None
|Title=Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
|RiskAllele=T
|Pval=6E-11
|OR=0.1800
|ORtxt=[NR] mg/dl decrease
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}